Safety of Nirsevimab for RSV in Infants with Heart or Lung Disease or Prematurity
- PMID: 35235733
- DOI: 10.1056/NEJMc2112186
Safety of Nirsevimab for RSV in Infants with Heart or Lung Disease or Prematurity
Similar articles
-
Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants.N Engl J Med. 2022 Mar 3;386(9):837-846. doi: 10.1056/NEJMoa2110275. N Engl J Med. 2022. PMID: 35235726 Clinical Trial.
-
Coadministration of Anti-Viral Monoclonal Antibodies With Routine Pediatric Vaccines and Implications for Nirsevimab Use: A White Paper.Front Immunol. 2021 Aug 11;12:708939. doi: 10.3389/fimmu.2021.708939. eCollection 2021. Front Immunol. 2021. PMID: 34456918 Free PMC article. Review.
-
Recent Trends in RSV Immunoprophylaxis: Clinical Implications for the Infant.Am J Perinatol. 2019 Jul;36(S 02):S63-S67. doi: 10.1055/s-0039-1691803. Epub 2019 Jun 25. Am J Perinatol. 2019. PMID: 31238362 Review.
-
Respiratory syncytial virus and recurrent wheeze in healthy preterm infants.N Engl J Med. 2013 May 9;368(19):1791-9. doi: 10.1056/NEJMoa1211917. N Engl J Med. 2013. PMID: 23656644 Clinical Trial.
-
Palivizumab for the prevention of respiratory syncytial virus infection.Can Fam Physician. 2010 Aug;56(8):769-72. Can Fam Physician. 2010. PMID: 20705882 Free PMC article.
Cited by
-
Assessment of effectiveness and impact of universal prophylaxis with nirsevimab for prevention of hospitalizations due to respiratory syncytial virus in infants. The NIRSE-GAL study protocol.Hum Vaccin Immunother. 2024 Dec 31;20(1):2348135. doi: 10.1080/21645515.2024.2348135. Epub 2024 May 13. Hum Vaccin Immunother. 2024. PMID: 38738683 Free PMC article.
-
Exploring parental perspectives: Maternal RSV vaccination versus infant RSV monoclonal antibody.Hum Vaccin Immunother. 2024 Dec 31;20(1):2341505. doi: 10.1080/21645515.2024.2341505. Epub 2024 May 9. Hum Vaccin Immunother. 2024. PMID: 38723786 Free PMC article.
-
Effectiveness of Nirsevimab Immunoprophylaxis Administered at Birth to Prevent Infant Hospitalisation for Respiratory Syncytial Virus Infection: A Population-Based Cohort Study.Vaccines (Basel). 2024 Apr 4;12(4):383. doi: 10.3390/vaccines12040383. Vaccines (Basel). 2024. PMID: 38675765 Free PMC article.
-
Respiratory Syncytial Virus Infections in Recipients of Bone Marrow Transplants: A Systematic Review and Meta-Analysis.Infect Dis Rep. 2024 Mar 29;16(2):317-355. doi: 10.3390/idr16020026. Infect Dis Rep. 2024. PMID: 38667752 Free PMC article. Review.
-
Will nirsevimab be the holy grail for prevention of respiratory syncytial virus lower respiratory tract infections in infants?Transl Pediatr. 2024 Mar 27;13(3):525-529. doi: 10.21037/tp-23-534. Epub 2024 Mar 8. Transl Pediatr. 2024. PMID: 38590379 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical